Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102
Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102
Phase I/II study of neoadjuvant chemoradiotherapy consisting of S-1 and cisplatin for patients with clinically resectable type 4 and large type 3 gastric cancer (OGSG1205)
胃癌術後補助化学療法時の栄養介入が予後に与える影響（OGSG1108試験の追加観察研究）